Bronchitol: Global Drug Overview, Product Profiles and Sales for CF by Country (2016-2025) - ResearchAndMarkets.com

DUBLIN--()--The "Bronchitol" report has been added to ResearchAndMarkets.com's offering.

Bronchitol is an inhaled dry powder formulation of mannitol, a naturally occurring monosaccharide that also acts as a mucolytic agent.

Once inhaled, Bronchitol has an osmotic effect that increases the hydration of airway surface liquid.

This facilitates mucociliary clearance in cystic fibrosis patients that have typically sticky mucus, alleviating some of the respiratory symptoms associated with the disease.

Key Topics Covered

  1. Drug Overview
  2. Product Profiles
  3. Bronchitol: Cystic fibrosis

List of Figures

Figure 1: Bronchitol for cystic fibrosis - SWOT analysis

Figure 2: The authors drug assessment summary of Bronchitol for cystic fibrosis

Figure 3: Bronchitol sales for cystic fibrosis across the US, Germany, and the UK, by country, 2016-25

List of Tables

Table 1: Bronchitol drug profile

Table 2: Bronchitol Phase III data in cystic fibrosis

Table 3: Bronchitol sales for cystic fibrosis across the US, Germany, and the UK, by country ($m), 2016-25

For more information about this report visit https://www.researchandmarkets.com/r/5hjc3k

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs